Proceedings of the 2006 annual meeting of the Fetal Alcohol Spectrum Disorders Study Group.
This article describes the proceedings of the 2006 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG), which was held in Baltimore, Maryland on June 24, 2006. The meeting was held in conjunction with the annual meeting of the Research Society on Alcoholism and was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism. The 2005-2006 FASDSG officers, Daniel J. Bonthius (President), Heather Carmichael Olson (Vice-President), and Jennifer Thomas (Secretary-Treasurer), organized the meeting. Nationally prominent speakers delivered plenary lectures on topics of newborn screening, ethics, and neuroscience. Selected members of the FASDSG provided brief scientific data (FASt) reports, describing new research findings. Representatives from national agencies involved in fetal alcohol syndrome (FAS) research, treatment, and prevention provided updates regarding priorities, funding, and agency activities. Presentations were also made by the 2006 Student Merit Award recipient and by the 2006 Rosett Award recipient. The meeting served as a forum for clinicians, neuroscientists, psychologists, social scientists, and other professionals to discuss recent advances in FAS research and to identify the most important gaps in the understanding of alcohol-induced teratology.
Bonthius
Daniel J
DJ
Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA, USA. daniel-bonthius@uiowa.edu
Olson
Heather Carmichael
HC
Thomas
Jennifer D
JD
D000818:Animals; D035843:Biomedical Research / Q000191:economics; D001921:Brain / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D002492:Central Nervous System Depressants / Q000009:adverse effects / Q000633:toxicity*; D000431:Ethanol / Q000633:toxicity*; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D005820:Genetic Testing; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D017628:Microglia / Q000187:drug effects; D015997:Neonatal Screening / Q000379:methods; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012109:Research Support as Topic; D012958:Societies, Scientific
D002492:Central Nervous System Depressants; D000431:Ethanol